Hepatic Cysts in Autosomal Dominant Polycystic Kidney Disease Gregory T. Everson, M.D.  Mayo Clinic Proceedings  Volume 65, Issue 7, Pages 1020-1025 (July 1990) DOI: 10.1016/S0025-6196(12)65165-9 Copyright © 1990 Mayo Foundation for Medical Education and Research Terms and Conditions

Fig. 1 Frequency of renal and hepatic cysts stratified by age in a population at risk for autosomal dominant polycystic kidney disease (ADPKD), as detected by real-time ultrasonography. Population at risk included 239 patients with ADPKD and 189 unaffected family members. Number of subjects in each decade is indicated at bottom. (From Gabow and associates.9 By permission of the American Association for the Study of Liver Diseases.) Mayo Clinic Proceedings 1990 65, 1020-1025DOI: (10.1016/S0025-6196(12)65165-9) Copyright © 1990 Mayo Foundation for Medical Education and Research Terms and Conditions

Fig. 3 Secretory response to intravenously administered bolus of secretin (1 U/kg) by hepatic cysts in two patients with autosomal dominant polycystic kidney disease. Cumulative volume secreted is plotted against time. After percutaneous puncture (t = −15 minutes), 15 minutes were allowed to elapse before starting the secretion study at t = 0. Secretin was administered as indicated, approximately 35 minutes after puncture of cysts and stimulated sustained secretion of fluid by cysts. (From Everson and associates.12 By permission of the American Association for the Study of Liver Diseases.) Mayo Clinic Proceedings 1990 65, 1020-1025DOI: (10.1016/S0025-6196(12)65165-9) Copyright © 1990 Mayo Foundation for Medical Education and Research Terms and Conditions